Therapeutic Asset Ratings

9,922 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Omo-103 Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P1	CC (43)
Onabotulinum Toxin A Hemorrhagic Stroke	University of Alberta	P1	CC (43)
Onabotulinum Toxin A Reversible Cerebral Vasoconstriction Syndrome	University of Alberta	P1	CC (43)
Onabotulinum Toxin A Stroke Disorder	University of Alberta	P1	CC (43)
Onc 206 Anaplastic Meningioma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Anaplastic Oligodendroglioma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Anaplastic Pleomorphic Xanthoastrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Grade II Meningioma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Childhood Choroid Plexus Neoplasm	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Central Nervous System Neoplasm	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Diffuse Astrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Ependymoma	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Anaplastic Ependymoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Glioma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Gliomatosis Cerebri	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Gliosarcoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Medulloblastoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Primitive Neuroectodermal Tumor	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Pilocytic Astrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Pineal Parenchymal Cell Neoplasm	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Pleomorphic Xanthoastrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Central Nervous System Cancer	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Spinal Cord Glioma	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Atypical Teratoid Rhabdoid Tumor	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Grade III Glioma	Sabine Mueller, MD, PhD	P1	CC (43)

Showing 3101 to 3125 of 9,922 assets

PreviousPage 125 of 397Next